Menopause Market Size, Share & Trends Report

Menopause Market Size, Share & Trends Analysis Report By Treatment (Dietary Supplements, OTC Pharma Products), By Region (North America, Europe, Latin America), And Segment Forecasts, 2024 - 2030

Report ID: GVR-4-68039-434-2
Number of Pages: 100
Format: Electronic (PDF)

Historical Range: 2018 - 2022
Industry: Healthcare

Market Segmentation

Menopause Treatment Outlook (Revenue, USD Million, 2018 - 2030)
- Dietary Supplements
- OTC pharma products
  - Hormonal
  - Non-hormonal
Menopause Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - U.S. Menopause Market, By Treatment
    - Dietary Supplements
    - OTC pharma products
      - Hormonal
      - Non-hormonal
  - Canada Menopause Market, By Treatment
    - Dietary Supplements
    - OTC pharma products
      - Hormonal
      - Non-hormonal
- Europe
  - UK Menopause Market, By Treatment
    - Dietary Supplements
    - OTC pharma products
      - Hormonal
      - Non-hormonal
  - Germany Menopause Market, By Treatment
    - Dietary Supplements
    - OTC pharma products
      - Hormonal
      - Non-hormonal
  - France Menopause Market, By Treatment
    - Dietary Supplements
    - OTC pharma products
      - Hormonal
      - Non-hormonal
  - Italy Menopause Market, By Treatment
    - Dietary Supplements
    - OTC pharma products
      - Hormonal
      - Non-hormonal
  - Spain Menopause Market, By Treatment
    - Dietary Supplements
    - OTC pharma products
      - Hormonal
      - Non-hormonal
  - Sweden Menopause Market, By Treatment
    - Dietary Supplements
    - OTC pharma products
      - Hormonal
      - Non-hormonal
  - Norway Menopause Market, By Treatment
    - Dietary Supplements
    - OTC pharma products
      - Hormonal
      - Non-hormonal
  - Denmark Menopause Market, By Treatment
    - Dietary Supplements
    - OTC pharma products
      - Hormonal
      - Non-hormonal
- Asia Pacific
  - Japan Menopause Market, By Treatment
    - Dietary Supplements
    - OTC pharma products
      - Hormonal
      - Non-hormonal
  - China Menopause Market, By Treatment
    - Dietary Supplements
    - OTC pharma products
      - Hormonal
      - Non-hormonal
  - India Menopause Market, By Treatment
    - Dietary Supplements
    - OTC pharma products
      - Hormonal
      - Non-hormonal
  - Australia Menopause Market, By Treatment
    - Dietary Supplements
    - OTC pharma products
      - Hormonal
      - Non-hormonal
  - Thailand Menopause Market, By Treatment
    - Dietary Supplements
    - OTC pharma products
      - Hormonal
      - Non-hormonal
  - South Korea Menopause Market, By Treatment
    - Dietary Supplements
    - OTC pharma products
      - Hormonal
      - Non-hormonal
- Latin America
  - Brazil Menopause Market, By Treatment
    - Dietary Supplements
    - OTC pharma products
      - Hormonal
      - Non-hormonal
  - Mexico Menopause Market, By Treatment
    - Dietary Supplements
    - OTC pharma products
      - Hormonal
      - Non-hormonal
  - Argentina Menopause Market, By Treatment
    - Dietary Supplements
    - OTC pharma products
      - Hormonal
      - Non-hormonal
- Middle East & Africa
  - South Africa Menopause Market, By Treatment
    - Dietary Supplements
    - OTC pharma products
      - Hormonal
      - Non-hormonal
  - Saudi Arabia Menopause Market, By Treatment
    - Dietary Supplements
    - OTC pharma products
      - Hormonal
      - Non-hormonal
  - UAE Menopause Market, By Treatment
    - Dietary Supplements
    - OTC pharma products
      - Hormonal
      - Non-hormonal
  - Kuwait Menopause Market, By Treatment
    - Dietary Supplements
    - OTC pharma products
      - Hormonal
      - Non-hormonal

Menopause Market Dynamics

Drivers: Growing Number Of Women Experiencing Menopause

There is an increase in the number of women experiencing menopause. Over 1 million women will reach menopause by 2025, making up approximately 12% of the global population. Vasomotor Symptoms (VMS) are shared by almost 75% of women reaching menopause. According to the first state of menopause study by Bonafide in July 2021, involving 1,000 women in the U.S. aged 40-65, 73% of women had common menopause symptoms & 61% of women reported vaginal dryness This can lead to an overall loss of productivity and quality of life, making treatment crucial. This creates a wide population pool to be served by menopause products, such as dietary supplements and Over-the-Counter (OTC) drugs, which can help relieve symptoms, including hot flashes, osteoporosis, night sweats, & vaginal atrophy.

Increasing Awareness About Menopause And Its Treatment

Menopause is a natural aspect in the lives of women after a certain age. An increase in the number of menopause-related campaigns has led to a rise in awareness about it and related symptoms. Since 2009, 18th October has been celebrated globally as World Menopause Day, while October is celebrated as menopause awareness month. This was started by collaborating with WHO and the International Menopause Society (IMS). The month is used to spread awareness, support women globally, recognize their challenges, and spread awareness about their treatment. Various organizations, such as North American Menopause Society (NAMS) and Meno Martha, work to increase awareness. Key regional players are running campaigns to raise awareness about women's health and the benefits of dietary supplements in managing the menopause transition.

Restraints: Social Stigma Associated With Menopause And Adverse Effects Of Products

A major portion of the market remains untapped due to social stigma associated with the condition. Women undergoing menopause, even in developed economies, feel that they are unable to discuss the condition due to the stigma associated with it. According to a survey by the Parliamentary Committee, UK, 1 in 3 women are missing work due to menopause symptoms and, overall, only 11 % of such women requested changes in the workplace to manage symptoms, indicating the stigma regarding the situation in 89% of such women. The problem is worsened by OTC products being unable to provide adequate treatment. At times, OTC products can fail to provide relief as they deliver fewer active ingredients to the body than prescription products. Key adverse effects of these products include headache, nausea, change in bowel movement, and dizziness. These factors have led to the reduced uptake of OTC drugs, diminishing the market growth.

What Does This Report Include?

This section will provide insights into the contents included in this menopause market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Menopause market qualitative analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Menopause market quantitative analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.